KHA-CARI guideline: Peritonitis treatment and prophylaxis

Nephrology

Volumn 19, Issue 2, 2014, Pages 69-71

  Walker, Amanda ^a   Bannister, Kym ^b   George, Charles ^c   Mudge, David ^f   Yehia, Maha ^g   Lonergan, Maureen ^e   Chow, Josephine ^d  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

^c ANZAC Research Institute   (Australia)

^d Western Renal Service   (Australia)

^e WOLLONGONG HOSPITAL   (Australia)

^f PRINCESS ALEXANDRA HOSPITAL   (Australia)

^g AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CEPHALOSPORIN; FLUCONAZOLE; GENTAMICIN; NYSTATIN; PSEUDOMONIC ACID; UROKINASE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CATHETER INFECTION; CATHETER REMOVAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; HUMAN; INCIDENCE; LAPAROSCOPY; MYCOSIS; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS CATHETER; PERITONITIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROPHYLAXIS; RISK REDUCTION;

CATHETER-RELATED INFECTIONS; HUMANS; PERITONEAL DIALYSIS; PERITONITIS; PRACTICE GUIDELINES AS TOPIC;

EID: 84892523927     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12152     Document Type: Article

References (4)

1. NHMRC. A Guide to the Development, Implementation and Evaluation of Clinical Practice Guidelines. Canberra: NHMRC, 1999.
2. Fried L, Abidi S, Bernardini J, Johnston JR, Piraino B,. Hospitalization in peritoneal dialysis patients. Am. J. Kidney Dis. 1999; 33: 927-933.
3. Mujais S,. Microbiology and outcomes of peritonitis in North America. Kidney Int. Suppl. 2006; 103: S55-62.
4. Davies SJ, Ogg CS, Cameron JS, Poston S, Noble WC,. Staphylococcus aureus nasal carriage, exit-site infection and catheter loss in patients treated with continuous ambulatory peritoneal dialysis (CAPD). Perit. Dial. Int. 1989; 9: 61-64.